Nutriband Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference
Nutriband Inc. subsidiary Active Intelligence will present its expanding wellness product line, including AI Tape and new performance and sleep patches, at the June 2026 ECRM conference to secure retail partnerships.
Nutriband Inc. (NASDAQ: NTRB) announced that its wholly owned subsidiary, Active Intelligence, will participate in the June 2026 ECRM conference, where it plans to showcase its expanding portfolio of wellness, recovery and performance-focused consumer products to buyers from major retail, pharmacy and healthcare organizations. The company will feature its existing AI Tape line and introduce new products including AI Performance Tape, AI Energy Patches and AI Sleep as it seeks to expand retail partnerships and distribution opportunities.
This move underscores Nutriband's strategy to diversify beyond its core pharmaceutical focus, leveraging Active Intelligence to tap into the growing consumer wellness market. By targeting major retailers and healthcare buyers at the ECRM conference, the company aims to secure shelf space and distribution channels that could significantly boost revenue from these non-pharmaceutical products. The introduction of AI Energy Patches and AI Sleep patches addresses the increasing consumer demand for convenient, transdermal solutions for energy and sleep support, areas where the market has seen substantial growth.
Nutriband is primarily engaged in the development of transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch incorporating AVERSA™ technology. This technology can be incorporated into any transdermal patch to prevent abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. The company's website is www.nutriband.com.
The ECRM conference, a key event for product introductions and retail networking, provides a platform for Active Intelligence to connect with decision-makers from major chains. Success at this event could accelerate the rollout of these new wellness products, potentially creating a new revenue stream for Nutriband and reducing its reliance on pharmaceutical approvals. For investors, the expansion into consumer wellness represents an opportunity to gauge the company's ability to execute in a faster-moving market segment.
For the latest news and updates relating to NTRB, visit the company's newsroom at https://ibn.fm/NTRB. The full press release can be viewed at https://ibn.fm/sZ1zJ.